Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy + EP chemotherapy with or without glycididazole sodium in unresectable locally advanced lung squamous cell carcinoma
ChiCTR1900027354Phase 4Not yet recruiting
- Sponsor
- Liaoning Province Cancer Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium glycididazole, etoposide and cisplatin in Pulmonary squamous cell carcinoma (2 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoints: Tumor SUVmax, Hypoxic zone and 1 more. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
sodium glycididazoleetoposidecisplatin
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR1900027354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027354.